Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

Saved in:

Bibliographic Details
Main Authors:	Hang Li, Hua Lu, Xi-Ping Shen, Xiao-Song Li
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2025-01-01
Series:	Clinical and Molecular Hepatology
Subjects:	hepatocellular carcinoma portal vein tumor thrombosis transarterial radioembolization tyrosine kinase inhibitor
Online Access:	http://e-cmh.org/upload/pdf/cmh-2024-0832.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identifying key predictors of mortality and liver decompensation in hepatocellular carcinoma patients treated with transarterial radioembolization
by: Mohammad Arabi, et al.
Published: (2025-05-01)

Efficacy and safety analysis of DEB-TACE for hepatocellular carcinoma with portal vein tumor thrombosis
by: Yan Zhang, et al.
Published: (2025-06-01)

Liver transplantation for advanced hepatocellular carcinoma: Controversy over portal vein tumor thrombosis
by: Kun-Ming Chan, et al.
Published: (2025-04-01)

Prognosticators of hepatocellular carcinoma with intrahepatic vascular invasion
by: Yuan-Chen Lo, et al.
Published: (2019-01-01)

Phosphorus-32 microspheres: A dual-modality transarterial radioembolization approach for hepatocellular carcinoma therapy and Anti-PD1 immunotherapy potentiation
by: Shipeng Dai, et al.
Published: (2025-10-01)

Comparative efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors versus tyrosine kinase inhibitors and immune checkpoint inhibitors alone in advanced hepatocellular carcinoma: a systematic review and meta-analysis
by: Hengyu Tian, et al.
Published: (2025-04-01)

Health Outcomes and Resource Consumption Analysis of Radioembolization with Y90 Glass Microspheres (TARE-Y90) Versus Transarterial Chemoembolization with Irinotecan (DEBIRI) in Patients with Liver Metastases from Colorectal Cancer in Spain
by: Juan José Ciampi-Dopazo, et al.
Published: (2025-03-01)

Efficacy of sorafenib plus transcatheter arterial chemoembolization in treating hepatocellular carcinoma with portal vein tumor thrombosis: A meta-analysis
by: Xu Li, et al.
Published: (2024-09-01)

Transarterial Radioembolization for Hepatocellular Carcinoma in Korea: Current Clinical Practices, Facility Requirements, and Patient Selection
by: Dongho Hyun
Published: (2025-07-01)

Portal vein thrombosis in patients with liver cirrhosis
by: Savić Željka, et al.
Published: (2024-01-01)

Management of hepatocellular carcinoma prior to liver transplantation: latest developments
by: Antoine Robert, et al.
Published: (2025-12-01)

Efficacy and safety of image-guided hypofractionated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective, multicenter study
by: Sang Min Lee, et al.
Published: (2025-04-01)

Management strategies for advanced hepatocellular carcinoma with portal vein tumor thrombosis
by: Jeayeon Park, et al.
Published: (2025-01-01)

Portal vein thrombosis after double installation of transjugular intrahepatic portosystemic stent (clinical observation)
by: M. S. Guska, et al.
Published: (2024-04-01)

Complications of Radioembolization: Prevention and Management
by: Gyoung Min Kim
Published: (2025-07-01)

Percutaneous transhepatic embolization of gastro-esophageal varices for the treatment of variceal bleeding in portal vein thrombosis secondary to hepatocellular carcinoma: A case report
by: Amol S. Rathod, et al.
Published: (2025-06-01)

Lenvatinib combined with anti-PD-1 antibodies plus locoregional treatment for initial unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter real-world study
by: Qi-Yu Chi, et al.
Published: (2025-07-01)

Ultrasound contrast microbubbles to predict the microsphere distribution during transarterial radioembolization with holmium microspheres, an in vitro proof of concept study
by: Jan L. van der Hoek, et al.
Published: (2025-12-01)

Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy
by: Yuki Ohya, et al.
Published: (2020-12-01)

Successful liver transplantation from a donor with occlusive portal vein thrombosis
by: M. S. Novruzbekov, et al.
Published: (2023-09-01)

Prognostic impact of tace combined with sorafenib or lenvatinib followed by regorafenib in recurrent hepatocellular carcinoma after liver transplantation: a retrospective study
by: Zhao-dan Ye, et al.
Published: (2025-07-01)

Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients
by: Liu CW, et al.
Published: (2025-05-01)

Prevalence and risk factors of portal vein thrombosis following hepatectomy: a systematic review and meta‑analysis
by: Yang Qun, et al.
Published: (2025-01-01)

MesoTIPS: Combined approach for the treatment of portal hypertension secondary to portal vein thrombosis – A brief report
by: Abbas Chamsuddin, et al.
Published: (2017-01-01)

Thrombosis of extrahepatic portal vein aneurysm immediately after laparoscopic distal gastrectomy: A case report
by: Kazunori Fukasawa, MD, et al.
Published: (2025-10-01)

Portal vein thrombosis in COVID-19 infection
by: Stefanie Sinz, et al.
Published: (2021-04-01)

Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
by: You-Bin Wang, et al.
Published: (2023-09-01)

Preparation of iodine-131 labeled Polyvinyl alcohol-collagen microspheres for radioembolization therapy of liver tumors
by: Yuhao Li, et al.
Published: (2025-03-01)

Etiology and Risk Factors for Splanchnic Vein Thrombosis in Non-Cirrhotic, Non-Neoplastic Patients: A Narrative Review
by: Mihaela Hostiuc, et al.
Published: (2025-05-01)

Transarterial Chemoembolization, Molecular Targeted Treatments, and Programmed Death-(Ligand)1 Inhibitors, for Hepatocellular Carcinoma with Lung Metastasis: A Retrospective Cohort Study
by: Lu J, et al.
Published: (2025-05-01)

Portal Vein Thrombosis in Liver Cirrhosis. Part 1: Epidemiology, Pathogenesis, Clinic, Diag-nosis, Impact on Prognosis
by: A. V. Yagoda, et al.
Published: (2024-06-01)

Portal vein thrombosis and Esophageal-Gastric variceal bleeding in cirrhosis: shared risk factors and causal relationship
by: Chanchan Lin, et al.
Published: (2025-07-01)

Combining Hepatic Arterial Interventional Therapies with Lenvatinib and Programmed Cell Death-1 Inhibitors for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Single-Center, Real-World Study
by: Shen X, et al.
Published: (2025-07-01)

Radioembolization: Technical Tips and Follow-Up Imaging
by: Hyo-Cheol Kim
Published: (2025-07-01)

Antithrombin III treatment for portal vein thrombosis after living donor liver transplantation: a case report
by: Yuta Hirata, et al.
Published: (2020-07-01)

Portal Vein Thrombosis in Liver Cirrhosis. Part 2: Treatment, Primary and Secondary Prevention
by: A. V. Yagoda, et al.
Published: (2024-08-01)

Risk Factors of Portal Vein Thrombosis in Patients with Different Child-Pugh Classes Liver Cirrhosis
by: M. Yu. Nadinskaia, et al.
Published: (2023-08-01)

Case Report: Fish bone-induced duodenal perforation leading to bile duct stones and portal vein thrombosis
by: Yuyi Shi, et al.
Published: (2025-04-01)

Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion
by: Kazuki Matsushita, et al.
Published: (2021-06-01)

Novel Insights Into Receptor Tyrosine Kinases in Pulmonary Arterial Hypertension
by: Wenze Wu, et al.
Published: (2025-08-01)